Thursday, January 09, 2014 11:00:39 AM
http://www.forbes.com/sites/karstenstrauss/2013/12/30/big-marijuana-is-it-the-future/
Michigan-based nutritional supplement company, Creative Edge Nutrition, is on course to becoming the first U.S. company to be allowed to distribute medicinal marijuana in Canada, says CEO Bill Chaaban. In November the company was notified by Canada’s federal health department, Health Canada, that it has been approved to grow, distribute, import and export medicinal marijuana and plant seeds through its Canadian subsidiary CEN Biotech.
A.P. Poll Finds Falling Resistance To Marijuana Legalization
Jacob SullumJacob Sullum
Contributor
Uruguay's President Signs Bill Legalizing Marijuana
Jacob SullumJacob Sullum
Contributor
If Marijuana Legalization Sends The Wrong Message To Teenagers, Why Aren't They Listening?
Jacob SullumJacob Sullum
Contributor
Creative Edge, which sells health supplements and trades for fractions of a penny on OTC Markets, reported less than $2 million in the first half of 2013 but Chaaban – an attorney licensed to practice in both the U.S. and Canada – says this latest play could catapult the company’s earnings into the stratosphere. “By the end of year five we’ll be doing $100 million in sales, with a margin of 80 percent.”
Currently, for medicinal users in Canada, marijuana costs between $5 and $6 CAD per gram (that’s between $4.70 and $5.60 in U.S. dollars). CEN Biotech’s cost to produce runs between 80 cents and $1 CAD per gram. Chaaban predicts the operation will be up and running and ready to begin shipping within seven months.
CEN Biotech’s new 58,000 square foot facility – still under construction in Lakeshore, Ontario, across the Detroit River from Michigan – has cost the company about $16 million CAD. Chaaban claims capital was raised from a pool of, ahem, ‘seed’ investors that includes companies that deal in alcohol and tobacco, entertainment industry players and professional sports figures. He would not provide specific names. Chaaban estimates that he owns roughly 4% of the company.
The level of oversight mandated by Health Canada has demanded CEN Biotech design their new facility like a high security penitentiary, says Chaaban, including night vision cameras, laser sensors, 24-hour security staff and tagging technology that will allow the organization to monitor the movement of every single plant. “There will be RF-ID (radio frequency ID) tags on every single seed.”
Also, no purchase of product by registered patients can be conducted in cash and CEN Biotech’s leadership team – made up of four lawyers, two doctors of pharmacy, two former law enforcement officers, an agricultural engineer and an executive of a drug company – has been vetted by the Royal Canadian Mounted Police.
Cannabis is used to treat the effects of glaucoma, Crohn’s disease, multiple sclerosis, nerve pain and chemotherapy, among other ailments. Health Canada had previously allowed individuals to apply for licenses to produce marijuana for medicinal use but increases in fire hazards, home invasions and crime have led the organization to push for a more regulated co-op system that requires fire and police approval, tracking and taxation, says Chaaban. Also, with so many producers, the organization had a hard time overseeing quality. “Too many people were applying to grow their own.”
Health Canada predicts that there will be half a million medicinal users in Canada within ten years but Chaaban feels that with the ease of access and assurance of consistency, that figure could be reached in two.
Not that Canada is CEN Biotech’s only market—the company’s 24 strains of plants will be exported to sources in Uruguay, Israel, The Netherlands, Mexico, Columbia, Iran and North Korea. Seeds from prime sources can be imported for use in the production facility.
Cannabis Day 2012, Vancouver. (image: Cannabis Culture on Flickr)
Cannabis Day 2012, Vancouver. (image: Cannabis Culture on Flickr)
As far as the United States market is concerned, Chaaban is betting that as more states adopt laws embracing medicinal marijuana, state governments will look for taxable product sources they feel have trustworthy tracking procedures and he wants CEN Biotech to be among them. “Once the feds come on board we’ll definitely enter the U.S. market.”
Chaaban’s confidence that the U.S. will come around to enacting more lax cannabis legislation is not unfounded. Most recently, Colorado residents are able to purchase marijuana thanks to a law allowing the sale (no prescription required) and regulated production of marijuana which went into effect this week. At present, the state has 24 open shops selling the product with hundreds of pending applications from entrepreneurs interested in providing some service in the new industr.,
Other publicly traded firms work in the medicinal marijuana space, including Cannabis Science, Inc.; Endocan Corporation; GW Pharmaceuticals and Medical Marijuana, Inc. Should medical marijuana continue to be embraced by states and federal governments, more players are likely to enter the market as growers, distributors and investors.
Recent PMCB News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 08:37:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/29/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:59:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM